Correlation Between Cannara Biotech and IShares Canadian

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cannara Biotech and IShares Canadian at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannara Biotech and IShares Canadian into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cannara Biotech and iShares Canadian HYBrid, you can compare the effects of market volatilities on Cannara Biotech and IShares Canadian and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannara Biotech with a short position of IShares Canadian. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannara Biotech and IShares Canadian.

Diversification Opportunities for Cannara Biotech and IShares Canadian

0.8
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Cannara and IShares is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Cannara Biotech and iShares Canadian HYBrid in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Canadian HYBrid and Cannara Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannara Biotech are associated (or correlated) with IShares Canadian. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Canadian HYBrid has no effect on the direction of Cannara Biotech i.e., Cannara Biotech and IShares Canadian go up and down completely randomly.

Pair Corralation between Cannara Biotech and IShares Canadian

Assuming the 90 days trading horizon Cannara Biotech is expected to generate 14.55 times more return on investment than IShares Canadian. However, Cannara Biotech is 14.55 times more volatile than iShares Canadian HYBrid. It trades about 0.04 of its potential returns per unit of risk. iShares Canadian HYBrid is currently generating about 0.19 per unit of risk. If you would invest  93.00  in Cannara Biotech on November 28, 2024 and sell it today you would earn a total of  36.00  from holding Cannara Biotech or generate 38.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Cannara Biotech  vs.  iShares Canadian HYBrid

 Performance 
       Timeline  
Cannara Biotech 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Cannara Biotech showed solid returns over the last few months and may actually be approaching a breakup point.
iShares Canadian HYBrid 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in iShares Canadian HYBrid are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy fundamental drivers, IShares Canadian is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Cannara Biotech and IShares Canadian Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cannara Biotech and IShares Canadian

The main advantage of trading using opposite Cannara Biotech and IShares Canadian positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannara Biotech position performs unexpectedly, IShares Canadian can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Canadian will offset losses from the drop in IShares Canadian's long position.
The idea behind Cannara Biotech and iShares Canadian HYBrid pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance